🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The goal of this prospective study is to evaluate if a higher radiation dos...
Status
Recruiting
Location
Erasmus MC
Start Date
2026-01-27
Trial ID
NCT07616297
Treatments Being Tested
This clinical study investigates the anti-inflammatory and anti-cancer prop...
Status
Not Yet Recruiting
Location
Linkou Chang Gung Memorial Hospital
Start Date
2026-01-01
Trial ID
NCT07248020
Treatments Being Tested
This is a Phase I dose escalation and expansion trial. The purpose of this ...
Status
Recruiting
Location
Huntsman Cancer Institute
Start Date
2015-05-07
Trial ID
NCT02390518
Treatments Being Tested
The BLEND RCT aims to evaluate the (cost-)effectiveness of same-day SBRT an...
Status
Recruiting
Location
University Medical Center Utrecht
Start Date
2022-10-15
Trial ID
NCT05575323
Treatments Being Tested
This trial tests how well personalized ultra fractionated stereotactic adap...
Status
Recruiting
Location
University of California at Los Angeles
Start Date
2024-10-25
Trial ID
NCT06572423
Treatments Being Tested
This study will test whether vaccination with viagenpumatucel-L combined wi...
Status
Completed
Location
University of Arizona Cancer Center
Start Date
2015-04-15
Trial ID
NCT02439450
Treatments Being Tested
Bladder cancer is the seventh most common cancer in the UK, with 10,399 new...
Status
Active Not Recruiting
Location
Riverina Cancer Care Centre
Start Date
2015-10-21
Trial ID
NCT02447549
The purpose of this study is to determine whether celecoxib is effective in...
Status
Unknown
Location
The third Affiliated Hospital of Guangxi Medical University
Start Date
2014-01
Trial ID
NCT02537925
Treatments Being Tested
Background:Moderate three week hypofractionated adjuvant radiotherapy sched...
Status
Recruiting
Location
Sanjoy Chatterjee
Start Date
2019-03-26
Trial ID
NCT03788213
This is an adaptive design, randomized controlled, Phase 3 clinical trial i...
Status
Terminated
Location
Kaiser Permanente Los Angeles Medical Center
Start Date
2017-10-27
Trial ID
NCT03149575